Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 12Neoplasms 8Prostatic Neoplasms 4Neoplasm Metastasis 4Lung Neoplasms 3Gastrointestinal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Sarcoma 2Pain 2Multiple Myeloma 2Melanoma 2Hematologic Neoplasms 2Fatigue 2Esophageal Neoplasms 2Carcinoma, Hepatocellular 2Weight Loss 1Uterine Cervical Neoplasms 1To Observe Whether the Fucoidan Can Improve the Quality of Life of the Such Patients Receiving the Neoadjuvant CCRT 1Thymus Neoplasms 1Thrombocytopenia 1Symptom Management 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Splenomegaly 1Speech 1Sexual Dysfunction, Physiological 1Sex Cord-Gonadal Stromal Tumors 1Sarcoma, Synovial 1Rectal Neoplasms 1

Interventions

Temozolomide 44Radiotherapy 20Magnetic Resonance Spectroscopy 13Irinotecan 13Carboplatin 11Bevacizumab 11Filgrastim 9Surgical Procedures, Operative 7Procarbazine 6sargramostim 5Vincristine 5Imatinib Mesylate 5Etoposide 5Erlotinib Hydrochloride 5Carmustine 5Biopsy 5etoposide phosphate 4Peripheral Blood Stem Cell Transplantation 4Lomustine 4Immunohistochemistry 4Cyclophosphamide 42-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4temsirolimus 3poly ICLC 3aldesleukin 3Thalidomide 3Surveys and Questionnaires 3Radiation 3Polymerase Chain Reaction 3Gadolinium DTPA 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Oligodendroglioma × Quality of Life × Clear all
NCT04708548 2023-05-15

Long Term Implications of Rare Brain Tumours'

University of Leeds

Completed
267 enrolled
CNS

Oligodendroglioma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡